In this study, we found that there were significant differences between patients with cognitive impairment only, T2DM, or T2DM with cognitive impairment in the levels of the complement proteins C1q, C3, C3b and the complement regulatory protein FH (Figure 1). This evidence concerns the gene VTN and Cognitive impairment.